These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7665118)

  • 1. [Evidence of luteotropic activity of chorionic gonadotropin in patients with controlled ovarian stimulation].
    Kably Ambe A; González Cervantes MM; Barrón Vallejo J; Serviere Zaragoza C; Cherem Cherem B
    Ginecol Obstet Mex; 1995 Jul; 63():308-11. PubMed ID: 7665118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Luteal phase support with hCG does not improve fecundity rate in human menopausal gonadotropin-stimulated cycles.
    Keenan JA; Moghissi KS
    Obstet Gynecol; 1992 Jun; 79(6):983-7. PubMed ID: 1579327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
    Krause BT; Ohlinger R
    Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled ovarian stimulation with exclusive FSH followed by stimulation with hCG alone, FSH alone or hMG.
    Gomes MK; Vieira CS; Moura MD; Manetta LA; Leite SP; Reis RM; Ferriani RA
    Eur J Obstet Gynecol Reprod Biol; 2007 Jan; 130(1):99-106. PubMed ID: 16835006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of leuprolide acetate on luteal phase function in women undergoing controlled ovarian hyperstimulation and intrauterine insemination.
    Duffy DA; Manzi D; Benadiva C; Maier D; Saunders M; Nulsen J
    Fertil Steril; 2006 Feb; 85(2):407-11. PubMed ID: 16595219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Luteal phase support in ovarian induction cycles using human chorionic gonadotropin or oral progestagens.
    Zayed FF; El-Jallad MF; Al-Chalabi HA
    Saudi Med J; 2003 Jan; 24(1):34-6. PubMed ID: 12590270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated endometrial maturation in the luteal phase of cycles utilizing controlled ovarian hyperstimulation: impact of gonadotropin-releasing hormone agonists versus antagonists.
    Saadat P; Boostanfar R; Slater CC; Tourgeman DE; Stanczyk FZ; Paulson RJ
    Fertil Steril; 2004 Jul; 82(1):167-71. PubMed ID: 15237007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian hyperstimulation syndrome following ovulation induction with human menopausal gonadotropin.
    Tulandi T; McInnes RA; Arronet GH
    Int J Fertil; 1984; 29(2):113-7. PubMed ID: 6148315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homologous intrauterine insemination in controlled ovarian hyperstimulation cycles: a comparison among three different regimens.
    Casadei L; Zamaro V; Calcagni M; Ticconi C; Dorrucci M; Piccione E
    Eur J Obstet Gynecol Reprod Biol; 2006 Dec; 129(2):155-61. PubMed ID: 16687201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine modifications associated with final oocyte maturation with gonadotropin-releasing hormone agonists vs. human chorionic gonadotropin in women undergoing intrauterine insemination.
    Díaz I; Guillén A; Pacheco A; Requena A; Garcia-Velasco JA
    J Reprod Med; 2008 Jan; 53(1):33-9. PubMed ID: 18251359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Luteotropic effect of human chorionic gonadotropin on human corpus luteum in early gestation (author's transl)].
    Fukushima E; Kanazawa M; Yanaihara T; Nakayama T
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Jun; 34(6):719-28. PubMed ID: 6212616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of human chorionic gonadotropin support of the corpus luteum during human gonadotropin therapy in women with anovulatory infertility.
    Messinis IE; Bergh T; Wide L
    Fertil Steril; 1988 Jul; 50(1):31-5. PubMed ID: 3133249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective, randomized study to evaluate the success rates using hCG, vaginal progesterone or a combination of both for luteal phase support.
    Ludwig M; Finas A; Katalinic A; Strik D; Kowalcek I; Schwartz P; Felberbaum R; Küpker W; Schöpper B; Al-Hasani S; Diedrich K
    Acta Obstet Gynecol Scand; 2001 Jun; 80(6):574-82. PubMed ID: 11380297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of human chorionic gonadotropin to clomiphene citrate ovulation induction therapy does not improve pregnancy outcomes and luteal function.
    Yilmaz B; Kelekci S; Savan K; Oral H; Mollamahmutoglu L
    Fertil Steril; 2006 Mar; 85(3):783-6. PubMed ID: 16500364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring of ovulation induction with HMG-HCG therapy by plasma estrogen and progesterone.
    Muechler EK; Kohler D; Huang KE
    Int J Fertil; 1981; 26(4):273-8. PubMed ID: 6120908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Peak follicular estradiol (E2) levels and midluteal progesterone/E2 ratios in ongoing pregnancies and nonconception cycles after ovulation induced with gonadotropins].
    Ellenbogen A; David H; Libal Y; Ballas S
    Harefuah; 1995 Dec; 129(11):455-6, 536. PubMed ID: 8846950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of urinary versus recombinant gonadotropin on serum P-selectin levels in vivo.
    Orvieto R; La Marca A; Badir W; Golan O; Bar J; Fisch B
    Gynecol Endocrinol; 2005 Apr; 20(4):185-7. PubMed ID: 16019359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hCG on prostaglandin synthesis and function of corpus luteum.
    Balmaceda JP; Valenzuela G; Eddy CA; Asch RH
    Obstet Gynecol; 1981 Apr; 57(4):505-8. PubMed ID: 7243104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early endocrine events in induced pregnancies.
    Radwanska E; Maclin V; Rana N; Henig I; Rawlins R; Dmowski WP
    Int J Fertil; 1988; 33(3):162-7. PubMed ID: 2899560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corpora lutea induced by gonadotrophin-releasing hormone treatment of anoestrous Welsh Mountain ewes: reduced sensitivity to luteinizing hormone in vivo and to chorionic gonadotrophin in vitro.
    Bramley TA; Stirling D; Menzies GS; Baird DT
    Reproduction; 2005 Jan; 129(1):61-73. PubMed ID: 15615899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.